Patients who used Wegovy and suffered qualifying injuries may file claims under the same legal theories
A agncia esclareceu que a importao de medicamentos sem registro s ocorre em situaes excepcionais, para uso pessoal e com prescrio mdica, cenrio que no se aplica aos casos investigados
62.9% of people treated with semaglutide 2.4 mg achieved resolution of steatohepatitis with no worsening of liver fibrosis compared to 34.1% on placebo
GLP-1 Medications: Work with natural hunger hormones Multiple complementary mechanisms Target biological causes of overeating Produce 10-22% average weight loss Much more effective than traditional options Medical Uses: FDA-Approved Indications: For Type 2 Diabetes: All GLP-1 medications originally approved for diabetes Improve blood sugar control Reduce A1C by 1-2 percentage points Lower risk of cardiovascular events For Chronic Weight Management: Semaglutide (Wegovy): Approved 2021 Tirzepatide (Zepbound): Approved 2023 Liraglutide (Saxenda): Approved 2014 Requirements for weight loss approval: BMI 30, or BMI 27 with weight-related condition (diabetes, hypertension, sleep apnea, etc.) Off-Label Use: Many doctors prescribe diabetes versions (Ozempic, Mounjaro) off-label for weight loss because: Identical medication to weight loss versions Sometimes better insurance coverage Same effectiveness regardless of indication on label This is legal and common medical practice
Chang S, Wang P, Han Y, Ma Q, Liu Z, Zhong S, Lu Y, Chen R, Sun L, Wu Q, et al
